Cardiff Lexingtn Corp

Good morning, everyone, and thank you for participating in today's conference call to discuss Cardiff Lexington's financial results for the first quarter ended March 31st, 2026. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to John Nesbitt and Walter Frank of IMS Investor Relations. Please go ahead.

Thank you, Operator. I would like to welcome everybody to the call today. Hosting the call are Carter Flexington CEO Alex Cunningham and CFO Matt Schaefer. I would like to take a moment to read the Safe Harbor Statement. This conference call contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. These forward-looking statements and terms such as anticipate, expect, intend, may, will, should, or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief, or current expectations of Cardiff Lexington and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those described in Cardiff Lexington's periodic reports filed with the SEC, and that actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, Carta-Flexington undertakes no obligation to update or revise forward-looking statements to reflect change conditions. I would now like to turn the call over to the CEO of Carta-Flexington, Alex Cunningham.

Thank you, Walter. Good morning, everyone, and thank you for joining our conference call today to discuss our first quarter 2026 results. I will start by providing an overview of our performance. progress, and strategy before turning the call over to Matt Schaefer, our Chief Financial Officer, for a deeper dive into our financial results. We will then open the call for a brief Q&A. Throughout the first quarter, we continued to expand and strengthen our clinical and operational teams across our 11 NOVA ortho and spine locations to support patient demand, best-in-class orthopedic medical care, and exceptional patient outcomes with a focus on higher-value surgical procedures. While revenues were below the first quarter last year, we were able to achieve positive adjusted EBITDA for the quarter. We remain very confident in our long-term growth strategy and ability to drive improved performance as we look to scale the business and capitalize on the attractive opportunities and growth market before us. During the quarter, we upgraded to the OTC QX best market, which is the highest level of the OTC markets. This upgrade represents a key milestone for our business and emphasizes our focus on investor visibility strong financial controls, and corporate governance. These items are foundational to our broader strategy to ultimately uplift to a US exchange and increase our access to working capital. As it stands, we are currently operating at a fraction of our total capacity, and in some cases, we are even having to delay treatment or turn patients away. Demand is strong, and with enhanced access to working capital, we will be able to support increased patient volume and procedural throughput without relying on higher-cost financing structures that have impacted our bottom line for several quarters now, despite consistent revenues and profitability on a non-GAAP basis. Our network of NOVA ortho and spine locations remains strong. With presences in key population centers throughout the state, we can effectively and efficiently provide the highest standard of medical care to our patients who represent a severely underserved population of the healthcare market. In addition to the markets we currently serve, we're receiving considerable interest from additional locations and communities throughout Florida, Georgia, and further up the broader mid-Atlantic and southeast U.S. along the I-75 corridor from Florida all the way to Michigan, which has been very encouraging. While I can't go into too much detail on this call, I'm pleased to say that we're currently in the process of opening a location in a new and exciting market, and we'll provide an update soon on this as new details become available. Before turning the call over to Matt, I wanted to provide a brief overview of our M&A, which continues to be a key component of our overall strategy. As many of you are already aware, we have three synergistic pillars that support our M&A growth strategy. The first is to target businesses with strong core cash flows that we can acquire, optimize, and integrate into our existing businesses. These can include physician practices with strong existing cash flows or prospective future cash flows that will help drive core reoccurring revenue for our business. The second is to acquire assets that are accretive to our current model and expand our geographic footprint through the acquisition of real estate, including ambulatory surgery centers and orthopedic clinics. And the third pillar is focused on driving long-term sustainable growth and value by acquiring and managing the accounts receivable balances of personal injury practices. In short, our goal is to accelerate our organic results and growth through proactive M&A that will be accretive to our business. While we want to be aggressive, we are also approaching M&A opportunities strategically to make sure that these acquisitions can be integrated efficiently and provide meaningful long-term value for our shareholders. With that, I will now hand the call over to our Chief Financial Officer, Matt Schaefer, to take a deeper dive into our financial results for the first quarter.